Cargando…

Risk of colorectal cancer after initiation of orlistat: matched cohort study

Objective To examine the risk of colorectal cancer after orlistat initiation in the UK population. Design Retrospective matched cohort study. Setting Data from the UK Clinical Practice Research Datalink from September 1998 to December 2008. Participants 33 625 adults aged 18 years or over who starte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jin-Liern, Meier, Christoph R, Sandler, Robert S, Jick, Susan S, Stürmer, Til
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754767/ https://www.ncbi.nlm.nih.gov/pubmed/23982291 http://dx.doi.org/10.1136/bmj.f5039

Ejemplares similares

β-Blockers and the Risk of Depression: A Matched Case–Control Study
por: Bornand, Delia, et al.
Publicado: (2022)

Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023)

Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007)

The Effect of Orlistat on Sterol Metabolism in Obese Patients
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008)

Macrocytic Anemia and Thrombocytopenia Induced by Orlistat
por: Palacios-Martinez, David, et al.
Publicado: (2013)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study
por: Schneider, Cornelia, et al.
Publicado: (2016)

Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011)

The Application of Quantitative (1)H-NMR for the Determination of Orlistat in Tablets
por: Sun, Shanshan, et al.
Publicado: (2017)

Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
por: Svendsen, Mette, et al.
Publicado: (2011)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

High Sensitivity of Giardia duodenalis to Tetrahydrolipstatin (Orlistat) In Vitro
por: Hahn, Juliane, et al.
Publicado: (2013)

Orlistat-Induced Gut Microbiota Modification in Obese Mice
por: Ke, Jing, et al.
Publicado: (2020)

Comment on: Suissa and Azoulay. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Bodmer, Michael, et al.
Publicado: (2013)

Postprandial Effect of Orlistat on the Peaking of Lipid Level After Sequential High Fat Meals
por: Gabriel, Frederick S., et al.
Publicado: (2012)

Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance
por: Kim, Dae Hun, et al.
Publicado: (2018)

Cancer risk in patients with chronic obstructive pulmonary disease
por: Schneider, Cornelia, et al.
Publicado: (2010)

Pharmacologically Treated Anxiety and Depression in People Diagnosed with von Willebrand Disease: Matched Cohort Study
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2023)

Clinical and economic considerations of antiobesity treatment: a review of orlistat
por: Zohrabian, Armineh
Publicado: (2010)

Taking Orlistat: Predicting Weight Loss over 6 Months
por: Hollywood, Amelia, et al.
Publicado: (2011)

Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase
por: Fako, Valerie E., et al.
Publicado: (2014)

An Unexpected Result of Obesity Treatment: Orlistat-Related Acute Pancreatitis
por: Kose, Murat, et al.
Publicado: (2015)

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin
por: Pamuk, Baris, et al.
Publicado: (2018)

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
por: Bodmer, Michael, et al.
Publicado: (2010)

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008)

No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study
por: Becker, Claudia, et al.
Publicado: (2015)

Selection of orlistat as a potential inhibitor for lipase from Candida species
por: Khedidja, Benarous, et al.
Publicado: (2011)

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan
por: Syed, Asghar Hussain, et al.
Publicado: (2020)

The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case Report
por: Jarrett, Zachary S., et al.
Publicado: (2021)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review
por: Hao, Xiaoqing, et al.
Publicado: (2023)

The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study
por: Mueller, Alexandra M., et al.
Publicado: (2021)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study
por: R. Charlier, Sarah H., et al.
Publicado: (2022)

Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2022)

Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
por: Halpern, Alfredo, et al.
Publicado: (2010)

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose
por: Grudén, Stefan, et al.
Publicado: (2021)

Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia
por: Chang, Ching-Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pphije8lp1qtdidv9hif06urp8